Product Information
TEMOZOLOMIDE 180 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $21.4132 per EA under NDC 65162080551. Its NADAC has been published 69 times since Nov 20, 2024.
Strength
180 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162080551
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
3/19/2025
Active Ingredients
TEMOZOLOMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203691On Market Since
4/3/2015
Pharmacological Classes
Price Statistics
The NADAC for TEMOZOLOMIDE 180 MG CAPSULE has been published 69 times since Nov 20, 2024, and over the history we have for it it has risen 25.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.4132 per EA |
|---|---|
| All-time high | $21.4132 (Mar 11, 2026) |
| All-time low | $17.0736 (Nov 20, 2024) |
| 52-week high | $21.4132 |
| 52-week low | $21.4132 |
| Median price | $21.4132 |
| Average price | $20.9205 |
| Largest weekly change | +12.7% (Dec 18, 2024) |
| Weeks tracked | 69 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMOZOLOMIDE 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMOZOLOMIDE 180 MG CAPSULE, manufactured by Amneal Pharmaceuticals LLC, is $21.4132 per EA (NDC 65162080551), effective Mar 11, 2026.
How has the price of TEMOZOLOMIDE 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has risen 25.4%. It has been tracked across 69 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for TEMOZOLOMIDE 180 MG CAPSULE?
Since Nov 20, 2024, the NADAC for TEMOZOLOMIDE 180 MG CAPSULE has ranged from a low of $17.0736 (Nov 20, 2024) to a high of $21.4132 (Mar 11, 2026), with a median of $21.4132 per EA.
Are there cheaper alternatives to TEMOZOLOMIDE 180 MG CAPSULE?
6 NADAC-published products share the same active ingredient, strength, and dosage form as TEMOZOLOMIDE 180 MG CAPSULE, but none are currently priced below it.
Who manufactures TEMOZOLOMIDE 180 MG CAPSULE?
TEMOZOLOMIDE 180 MG CAPSULE (NDC 65162080551) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification